Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.34T | 2.81T | 1.63T | 1.58T | 1.42T | 1.33T | Gross Profit |
697.55B | 1.17T | -14.62B | -348.00M | -43.45B | -73.36B | EBIT |
376.67B | 360.71B | 360.57B | 292.88B | 258.81B | 269.68B | EBITDA |
592.29B | 834.22B | 732.43B | 829.75B | 599.09B | 712.74B | Net Income Common Stockholders |
369.90B | 346.13B | 290.34B | 317.38B | 192.38B | 302.70B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
992.75B | 1.05T | 3.47T | 3.13T | 2.96T | 2.61T | Total Assets |
16.50T | 16.32T | 15.27T | 14.27T | 13.56T | 13.07T | Total Debt |
6.39T | 6.20T | 5.72T | 4.87T | 4.72T | 4.62T | Net Debt |
5.39T | 5.17T | 4.49T | 3.91T | 3.77T | 3.63T | Total Liabilities |
12.34T | 12.30T | 11.84T | 10.90T | 10.46T | 10.00T | Stockholders Equity |
4.07T | 3.94T | 3.36T | 3.26T | 3.03T | 2.99T |
Cash Flow | Free Cash Flow | ||||
681.09B | 42.53B | -166.99B | 186.07B | 341.72B | 49.55B | Operating Cash Flow |
1.06T | 1.24T | 913.09B | 1.10T | 1.10T | 1.04T | Investing Cash Flow |
-949.32B | -1.37T | -1.10T | -808.85B | -1.21T | -1.47T | Financing Cash Flow |
14.18B | -85.48B | 438.31B | -306.62B | 39.88B | 288.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $50.34B | 10.69 | 28.29% | 1.40% | 9.42% | 128.55% | |
71 Outperform | $22.78B | 8.21 | 18.60% | 2.00% | 1.22% | 4.96% | |
69 Neutral | $23.26B | 10.72 | 8.65% | 3.22% | 0.31% | 34.40% | |
68 Neutral | $6.17B | 10.98 | 17.46% | 8.02% | 9.07% | ― | |
66 Neutral | $2.85B | 3.20 | 136.84% | 10.89% | -5.16% | 59.60% | |
64 Neutral | $12.77B | 9.71 | 7.85% | 78.05% | 12.07% | -7.97% | |
63 Neutral | $11.06B | 26.47 | 3.84% | 3.33% | -2.99% | -43.64% |